76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Derwent London PLC
Closed
SectorFinance
2,046 -0.49
Overview
Share price change
24h
Min
2012
Max
2062
Income | 171M 143M |
|---|---|
Sales | -18M 127M |
P/E Sector Avg | 20 24.617 |
Dividend yield | 3.91 |
Profit margin | 113.181 |
Employees | 201 |
EBITDA | -8.6M 69M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +9.35% upside |
Dividend yield Sector Avg | 3.91% 4.23% |
|---|---|
Next Earnings | 12 Aug 2025 |
Next Ex Dividend date | 4 Sept 2025 |
Market Cap | 196M 2.3B |
|---|---|
Previous open | 2046.49 |
Previous close | 2046 |
News Sentiment
By Acuity
50%
50%
201 / 538 Finance
Derwent London PLC Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Derwent London PLC Forecast
Price Target
By TipRanks
9.35% upside
12 Months Forecast
Average 2,259.25 GBX 9.35%
High 2,767 GBX
Low 1,820 GBX
Based on 5 Wall Street analysts offering 12 month price targets forDerwent London PLC - Dist in the last 3 months.
Sentiment
By Acuity
201 / 538 Finance
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Derwent London PLC
Derwent London plc owns 63 buildings in a commercial real estate portfolio predominantly in central London valued at £4.8 billion as at 30 June 2024, making it the largest London office-focused real estate investment trust (REIT). Our experienced team has a long track record of creating value throughout the property cycle by regenerating our buildings via redevelopment or refurbishment, effective asset management and capital recycling. We typically acquire central London properties off-market with low capital values and modest rents in improving locations, most of which are either in the West End or the Tech Belt. We capitalise on the unique qualities of each of our properties - taking a fresh approach to the regeneration of every building with a focus on anticipating tenant requirements and an emphasis on design. Reflecting and supporting our long-term success, the business has a strong balance sheet with modest leverage, a robust income stream and flexible financing. We are frequently recognised in industry awards for the quality, design and innovation of our projects. Landmark buildings in our 5.3 million sq ft portfolio include 1 Soho Place W1, 80 Charlotte Street W1, Brunel Building W2, White Collar Factory EC1, Angel Building EC1, 1-2 Stephen Street W1, Horseferry House SW1 and Tea Building E1. As part of our commitment to lead the industry in mitigating climate change, Derwent London has committed to becoming a net zero carbon business by 2030, publishing its pathway to achieving this goal in July 2020. Our science-based carbon targets validated by the Science Based Targets initiative (SBTi). In 2013 the Company launched a voluntary Community Fund which has to date supported over 160 community projects in the West End and the Tech Belt. The Company is a public limited company, which is listed on the London Stock Exchange and incorporated and domiciled in the UK. The address of its registered office is 25 Savile Row, London, W1S 2ER.
